Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young-Tae Lee

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Nature Communications|May 20, 2021
Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatinYoung-Tae Lee, Alex Ayoub, Sang-Ho Park, et al.
Virology|June 5, 2019
A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virusYouri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Immunology|March 21, 2014
Distinct B-cell populations contribute to vaccine antigen-specific antibody production in a transgenic mouse modelEunju O, Eun-Ju Ko, Min-Chul Kim, et al.
Biochemistry|September 23, 2008
Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognitionYoung-Tae Lee, Yoana N Dimitrova, Gabriela Schneider, et al.
Nutrients|February 7, 2015
Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replicationJong Seok Lee, Yu-Na Lee, Young-Tae Lee, et al.
Virology|July 17, 2019
Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virusKi-Hye Kim, Young-Tae Lee, Soojin Park, et al.
Frontiers in Immunology|December 26, 2017
Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of MiceYu-Jin Kim, Young-Tae Lee, Min-Chul Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2016
Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza VaccineEun-Ju Ko, Young-Tae Lee, Ki-Hye Kim, et al.
Lupus|July 8, 2022
Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humansSehwan Chun, Chan-Bum Choi, Min S Kim, et al.
Vaccines|September 23, 2018
Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza VirusKi-Hye Kim, Young-Man Kwon, Young-Tae Lee, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Nature Communications|May 20, 2021
Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatinYoung-Tae Lee, Alex Ayoub, Sang-Ho Park, et al.
Virology|June 5, 2019
A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virusYouri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Immunology|March 21, 2014
Distinct B-cell populations contribute to vaccine antigen-specific antibody production in a transgenic mouse modelEunju O, Eun-Ju Ko, Min-Chul Kim, et al.
Biochemistry|September 23, 2008
Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognitionYoung-Tae Lee, Yoana N Dimitrova, Gabriela Schneider, et al.
Nutrients|February 7, 2015
Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replicationJong Seok Lee, Yu-Na Lee, Young-Tae Lee, et al.
Virology|July 17, 2019
Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virusKi-Hye Kim, Young-Tae Lee, Soojin Park, et al.
Frontiers in Immunology|December 26, 2017
Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of MiceYu-Jin Kim, Young-Tae Lee, Min-Chul Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2016
Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza VaccineEun-Ju Ko, Young-Tae Lee, Ki-Hye Kim, et al.
Lupus|July 8, 2022
Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humansSehwan Chun, Chan-Bum Choi, Min S Kim, et al.
Vaccines|September 23, 2018
Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza VirusKi-Hye Kim, Young-Man Kwon, Young-Tae Lee, et al.
Pageof 11